ArticleClinical and translational medicine2020

EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients.

Qiufan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.